spacer
spacer

PDBsum entry 4ztz

Go to PDB code: 
protein dna_rna ligands metals Protein-protein interface(s) links
DNA binding protein/DNA PDB id
4ztz

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
983 a.a.
363 a.a.
DNA/RNA
Ligands
DCP
Metals
_MG ×2
PDB id:
4ztz
Name: DNA binding protein/DNA
Title: Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase
Structure: DNA polymerase subunit gamma-1. Chain: a. Fragment: unp residues 30-1239. Synonym: mitochondrial DNA polymerase catalytic subunit,polg-alpha. Engineered: yes. DNA polymerase subunit gamma-2, mitochondrial. Chain: b, c. Synonym: DNA polymerase gamma accessory 55 kda subunit,p55, mitochondrial DNA polymerase accessory subunit,mtpolb,polg-beta.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: polg, mdp1, polg1, polga. Expressed in: insect cell expression vector ptie1. Expression_system_taxid: 266783. Gene: polg2, mtpolb. Synthetic: yes. Synthetic construct.
Resolution:
3.44Å     R-factor:   0.281     R-free:   0.320
Authors: M.R.Szymanski,Y.W.Yin
Key ref: M.R.Szymanski et al. (2015). Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase. Embo J, 34, 1959-1970. PubMed id: 26056153 DOI: 10.15252/embj.201591520
Date:
15-May-15     Release date:   23-Sep-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P54098  (DPOG1_HUMAN) -  DNA polymerase subunit gamma-1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1239 a.a.
983 a.a.*
Protein chains
Pfam   ArchSchema ?
Q9UHN1  (DPOG2_HUMAN) -  DNA polymerase subunit gamma-2, mitochondrial from Homo sapiens
Seq:
Struc:
485 a.a.
363 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

DNA/RNA chains
  G-C-G-A-T-A-C-G-G-C-A-C-T-G-G-C-C-C-T-C-G-T-C-T-T 25 bases
  A-A-G-A-C-G-A-G-G-G-C-C-A-G-T-G-C-C-G-T-A-DOC 22 bases

 Enzyme reactions 
   Enzyme class 1: Chain A: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 2: Chains B, C: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.15252/embj.201591520 Embo J 34:1959-1970 (2015)
PubMed id: 26056153  
 
 
Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase.
M.R.Szymanski, V.B.Kuznetsov, C.Shumate, Q.Meng, Y.S.Lee, G.Patel, S.Patel, Y.W.Yin.
 
  ABSTRACT  
 
The human DNA polymerase gamma (Pol γ) is responsible for DNA replication in mitochondria. Pol γ is particularly susceptible to inhibition by dideoxynucleoside-based inhibitors designed to fight viral infection. Here, we report crystal structures of the replicating Pol γ-DNA complex bound to either substrate or zalcitabine, an inhibitor used for HIV reverse transcriptase. The structures reveal that zalcitabine binds to the Pol γ active site almost identically to the substrate dCTP, providing a structural basis for Pol γ-mediated drug toxicity. When compared to the apo form, Pol γ undergoes intra- and inter-subunit conformational changes upon formation of the ternary complex with primer/template DNA and substrate. We also find that the accessory subunit Pol γB, which lacks intrinsic enzymatic activity and does not contact the primer/template DNA directly, serves as an allosteric regulator of holoenzyme activities. The structures presented here suggest a mechanism for processivity of the holoenzyme and provide a model for understanding the deleterious effects of Pol γ mutations in human disease. Crystal structures of the mitochondrial DNA polymerase, Pol γ, in complex with substrate or antiviral inhibitor zalcitabine provide a basis for understanding Pol γ-mediated drug toxicity.
 

 

spacer

spacer